InvestorsHub Logo
Followers 798
Posts 27022
Boards Moderated 0
Alias Born 09/11/2013

Re: BoilerRoom post# 28781

Tuesday, 03/14/2017 9:00:36 PM

Tuesday, March 14, 2017 9:00:36 PM

Post# of 106839
hey BoilerRoom...good to see you here in the house. Moving forward, it looks like the company may need to hop over four important steps in short term. Every step will have an effect on the PPS movement.

Step 1. RATD decision by FDA, if affirmative, will move the PPS northward quite a bit.

Step 2. Results of clinical trials, could be released within the next few weeks/months or earlier. If results are positive and robust, the PPS would move upward fast and furiously.

Step 3. Fast track designation by FDA, if granted, will produce strong positive effects on PPS. I believe RATD and fast track designation are some how connected (but not sure 100%).

Step 4. FDA decision on the drug approval submission, if affirmative, will move the PPS up in an epic proportion.

Needless to say, if step 2 is negative, then steps 3 and 4 would not follow, until such time when the company re-submits.

Meanwhile, if steps 1 and 2 are positive, there could be a buyout offer on the table. All bets are off in this scenario.

I expect all the four steps could be completed within a reasonable time frame, depending upon how close the company is with respect to finishing the clinical trials.

If all the four steps come to fruition in a positive manner, the PPS could be trading in the dollar land. We'll see.

Go $$USRM$$

All imho, not an investment advice. Do your own DD and trade at your own risks.